参考文献/References:
[1] Kurisu S, Sato HT, Ishihara M, et al. Tako-tsubo-like left ventricular dysfunction with ST-segment elevation: a novel cardiac syndrome mimicking acute myocardial infarction[J]. Am Heart J, 2002, 143(3):448-455.
[2] Lyon AR, Bossone E, Schineider B, et al. Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology [J]. Eur J Heart Fail, 2016,18(1):8-27.
[3] Ghadri JR, Wittstein IS, Prasad A, et al. International expert consensus document on Takotsubo syndrome (part II): diagnostic workup, outcome, and management[J]. Eur Heart J, 2018, 39(22):2047-2062.
[4] Deshmukh A, Kumar G, Pant S, et al. Prevalence of Takotsubo cardiomyopathy in the United States[J]. Am Heart J, 2012, 164(1):66-71.e1.
[5] Zelinka T, Petrák O, Turková H, et al. High incidence of cardiovascular complications in pheochromocytoma[J]. Horm Metab Res, 2012, 44(05):379-384.
[6] Prejbisz A, Lenders JW, Eisenhofer G, et al. Cardiovascular manifestations of phaeochromocytoma[J]. J Hypertens, 2011, 29(11):2049-2060.
[7] Lenders JWM, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab, 1915, 99(6):1915.
[8] Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary:a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines[J]. Hypertension, 2017, 19(2):213-221.
[9] Wiswell JG, Crago RM. Reversible cardiomyopathy with pheochromocytoma[J]. Trans Am Clin Climatol Assoc, 1969, 80:185-195.
[10] Shaw TR, Rafferty P, Tait GW. Transient shock and myocardial impairment caused by phaeochromocytoma crisis[J]. Br Heart J, 1987, 57(2):194-198.
[11] Zhang R, Gupta D, Albert SG. Pheochromocytoma as a reversible cause of cardiomyopathy: Analysis and review of the literature[J]. Int J Cardiol, 2017, 249:319-323.
[12] Prasad A, Lerman A, Rihal CS. Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction[J]. Am Heart J, 2008, 155(3):408-417.
[13] 王玮,金叔宣,沈学东,.嗜铬细胞瘤引起的Takotsubo心肌病一例[J].中华心血管病杂志, 2017, (10): 891-2.
[14] 李西,刘燕娜,章春泉,.嗜铬细胞瘤致Takotsubo型心肌病超声表现1例[J].中国医学影像技术, 2017, (9): 1443-5.
[15] Gagnon N, Mansour S, Bitton Y, et al. Takotsubo-like cardiomyopathy in a large cohort of patients with pheochromocytoma and paraganglioma[J]. Endocr Pract, 2017,23(10):1178-1192.
[16] Templin C, Ghadri JR,Diekmann J,et al. Clinical features and outcomes of Takotsubo (stress) cardiomyopathy[J]. N Engl J Med., 2015, 373(10):929-938.
[17] Bergen NHV, Lyon JK, Edens RE. Takotsubo-like cardiomyopathy in a 17-year-old male with a pheochromocytoma[J]. Pediatr Cardiol,2009, 30(2):184-187.
[18] Yhassan S. Clinical features and outcome of pheochromocytoma-induced Takotsubo syndrome: analysis of 80 published cases[J]. Am J Cardiol, 2016, 117(11):1836-1844.
[19] Batisse-Lignier M, Pereira B, Motreff P, et al. Acute and chronic pheochromocytoma-induced cardiomyopathies: different prognoses?: a systematic analytical review[J]. Medicine (Baltimore), 2015, 94(50):e2198.
[20] Ghadri JR, Cammann VL, Napp LC, et al. Differences in the clinical profile and outcomes of typical and atypical Takotsubo syndrome: data from the international Takotsubo registry[J]. JAMA Cardiol, 2016, 1(3):335-340.
[21] Wittstein IS,Thiemann DR,Lima JAC,et al. Neurohumoral features of myocardial stunning due to sudden emotional stress [J]. N Engl J Med, 2005, 352(6): 539-548.
[22] Yhassan S, Henareh L. Plasma catecholamine levels in patients with takotsubo syndrome: Implications for the pathogenesis of the disease[J]. Int J Cardiol, 2015, 181:35-38.
[23] Sharkey SW, Windenburg DC, Lesser JR, et al. Natural history and expansive clinical profile of stress (Tako-Tsubo) cardiomyopathy[J]. J Am Coll Cardiol, 2010, 55(4):333-341.
[24] Jang SY, Yang DH, Lee SH, et al. Recurrent catecholamine-induced cardiomyopathy in a patient with a pheochromocytoma[J]. Korean Circ J, 2009, 39(6):254-257.
[25] Ferreira VM, Marcelino M, Piechnik SK, et al. Pheochromocytoma is characterized by catecholamine-mediated myocarditis, focal and diffuse myocardial fibrosis, and myocardial dysfunction[J]. J Am Coll Cardiol, 2016, 67(20):2364-2374.